A Phase II Open Label Multicenter Study of PSMA ADC in Subjects with Castration-resistant Metastatic Prostate Cancer

Conditions

Cancer | Prostate

What is the purpose of this trial?

The objective of PSMA ADC 2301 in subjects with progressive, CRMPC is to assess the anti-tumor activity and tolerability of PSMA ADC.


Participation Guidelines

Age:
18 Years and older
Gender:
Male

Click here for detailed information about who can participate in this trial.


Sponsor:
PSMA Development Company LLC
Dates:
01/11/2013
Last Updated:
Study HIC#:
1211011046